21-Jan-16 LG Life Sciences will start selling Korea's first diabetes treatment Zemiglo in the global market this year. The Korean drugmaker sealed licensing partnerships with Sanofi and Stendhal in 2013, and will begin selling the new treatment in India and five countries in Central America from March 2016. [image: LG / Business Korea]

19-Jan-16 Currently, there is no global standard for mHealth in clinical trials, and the use of wearable devices raise regulatory challenges as sponsors question whether regulatory agencies in Asia and globally will accept mHealth data. Of particular concern are the expectations around safety monitoring. [image: BioSpectrum]

15-Jan-16 The Korean government plans to expand the geographical scope, size and targets of its third telemedicine system test run. Currently, the Ministry of National Defense is practicing telemedicine at 40 different locations after starting the service with two units in December 2014. [image: Yonhap News]

14-Jan-16 Unsafe use of medication is a major issue in both developed and developing countries, causing millions of injuries and costing USD4 bn annually. 10% of patients worldwide are affected, said a WHO report. "A global concerted effort is needed to address patient medication safety... Communication has become the buzzword," said Dr. SD Gupta, President of IIHMR University in Jaipur. [image: Keval News]

18-Dec-15 There's been a lot going on in emerging markets in 2015. Here's a look back at 12 notable Medtech growth markets stories you may have missed, month-by-month, including "India’s medical devices sector opens up", "Telstra's investment in e-health tops AUD100 mn", "Brazil medical equipment consumption down 4%", "China’s private hospital sector believes in Digital Health" and more.